GE HealthCare Technologies Inc. (GEHC)
GEHC or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency
GE HealthCare launches ReadyFix in the United States, a remote fleet management tool for MAC VU360 ECGs to boost device uptime and efficiency across hospitals.
GEHC Strengthens AI Fetal Ultrasound via Diagnoly Collaboration
GE HealthCare and Diagnoly unite to embed AI fetal screening in Voluson ultrasounds, expanding FDA-cleared tools to drive software-led growth and differentiation.
GE HealthCare Technologies Pops, And The Upside Isn't Over Yet
GE HealthCare Technologies delivered strong Q4 2025 results, with revenue and adjusted EPS exceeding analyst expectations and robust segmental growth. GEHC remains a 'buy' as shares are attractively valued relative to peers, despite recent outperformance and an absolute valuation near fair value. Key growth drivers include the Imaging and Pharmaceutical Diagnostics segments, innovation in cloud-first imaging, and strategic acquisitions like Intelerad.
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
GEHC tops Q4 EPS and revenue estimates as Imaging and PDx drive growth, but net margin slides on tariffs and product mix.
Compared to Estimates, GE HealthCare (GEHC) Q4 Earnings: A Look at Key Metrics
The headline numbers for GE HealthCare (GEHC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Beat Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.45 per share a year ago.
GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut
GE HealthCare's Allia Moveo wins FDA and CE clearance, enabling commercialization of a mobile C-arm with AI guidance, compact design and early global installs.
GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy?
GEHC heads into fourth-quarter earnings with steady demand and strong product momentum, though tariffs and investments may keep margins in focus.
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Exploring Analyst Estimates for GE HealthCare (GEHC) Q4 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for GE HealthCare (GEHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
